201 related articles for article (PubMed ID: 33924991)
1. Myocardial Hypertrophy and Fibrosis Are Associated with Cardiomyocyte Beta-Catenin and TRPC6/Calcineurin/NFAT Signaling in Spontaneously Hypertensive Rats with 5/6 Nephrectomy.
Bogdanova E; Beresneva O; Galkina O; Zubina I; Ivanova G; Parastaeva M; Semenova N; Dobronravov V
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924991
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular remodeling with exercise in hypertension.
Kolwicz SC; MacDonnell SM; Renna BF; Reger PO; Seqqat R; Rafiq K; Kendrick ZV; Houser SR; Sabri A; Libonati JR
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1361-8. PubMed ID: 19666835
[TBL] [Abstract][Full Text] [Related]
3. Puerarin ameliorates myocardial remodeling of spontaneously hypertensive rats through inhibiting TRPC6-CaN-NFATc3 pathway.
Yan J; Honglei Y; Yun W; Sheng D; Yun H; Anhua Z; Na F; Min L; Dandan S; Jing W; Junming T; Wenjun Z; Xiju H
Eur J Pharmacol; 2022 Oct; 933():175254. PubMed ID: 36087696
[TBL] [Abstract][Full Text] [Related]
4. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
Ennis IL; Garciarena CD; Escudero EM; Pérez NG; Dulce RA; Camilión de Hurtado MC; Cingolani HE
Can J Physiol Pharmacol; 2007; 85(3-4):301-10. PubMed ID: 17612638
[TBL] [Abstract][Full Text] [Related]
5. Moderate Exercise in Spontaneously Hypertensive Rats Is Unable to Activate the Expression of Genes Linked to Mitochondrial Dynamics and Biogenesis in Cardiomyocytes.
Quiroga C; Mancilla G; Oyarzun I; Tapia A; Caballero M; Gabrielli LA; Valladares-Ide D; Del Campo A; Castro PF; Verdejo HE
Front Endocrinol (Lausanne); 2020; 11():546. PubMed ID: 32973679
[TBL] [Abstract][Full Text] [Related]
6. Hypericin Alleviates Chronic Kidney Disease-induced Left Ventricular Hypertrophy by Regulation of FGF23-FGFR4 Signaling Pathway.
Liu M; Cheng L; Ye Q; Liu H; Shu C; Gao H; Liu X; Zhang X; Chen G
J Cardiovasc Pharmacol; 2024 Jun; 83(6):588-601. PubMed ID: 38547517
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibition normalizes beta-adrenergic responsiveness in the spontaneously hypertensive rat.
MacDonnell SM; Kubo H; Harris DM; Chen X; Berretta R; Barbe MF; Kolwicz S; Reger PO; Eckhart A; Renna BF; Koch WJ; Houser SR; Libonati JR
Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3122-9. PubMed ID: 17827263
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway.
Chen Y; Chang Y; Zhang N; Guo X; Sun G; Sun Y
Cell Physiol Biochem; 2018; 46(3):1009-1018. PubMed ID: 29669326
[TBL] [Abstract][Full Text] [Related]
9. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.
Gao H; Wang F; Wang W; Makarewich CA; Zhang H; Kubo H; Berretta RM; Barr LA; Molkentin JD; Houser SR
J Mol Cell Cardiol; 2012 Nov; 53(5):657-67. PubMed ID: 22921230
[TBL] [Abstract][Full Text] [Related]
10. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.
Kuwahara K; Wang Y; McAnally J; Richardson JA; Bassel-Duby R; Hill JA; Olson EN
J Clin Invest; 2006 Dec; 116(12):3114-26. PubMed ID: 17099778
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of the Wnt signaling pathway contributes to the cardiac protection of exercise training in spontaneously hypertensive rats].
Guo JF; Li MW; Shi BY; Zhang Y; Li N; Wang HJ
Sheng Li Xue Bao; 2022 Oct; 74(5):773-782. PubMed ID: 36319100
[TBL] [Abstract][Full Text] [Related]
12. TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation.
Kirschmer N; Bandleon S; von Ehrlich-Treuenstätt V; Hartmann S; Schaaf A; Lamprecht AK; Miranda-Laferte E; Langsenlehner T; Ritter O; Eder P
PLoS One; 2016; 11(12):e0168446. PubMed ID: 27992507
[TBL] [Abstract][Full Text] [Related]
13. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
14. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
15. Hypertension and the Kidney: Reduced Kidney Mass Is Bad for Both Normotensive and Hypertensive Rats.
Ware K; Yildiz V; Xiao M; Medipally A; Hemminger J; Scarl R; Satoskar AA; Hebert L; Ivanov I; Biederman L; Brodsky SV
Am J Hypertens; 2021 Nov; 34(11):1196-1202. PubMed ID: 34181718
[TBL] [Abstract][Full Text] [Related]
16. Olmesartan attenuates cardiac hypertrophy and improves cardiac diastolic function in spontaneously hypertensive rats through inhibition of calcineurin pathway.
Fu M; Zhou J; Xu J; Zhu H; Liao J; Cui X; Sun A; Fu M; Zou Y; Hu K; Ge J
J Cardiovasc Pharmacol; 2014 Mar; 63(3):218-26. PubMed ID: 24603116
[TBL] [Abstract][Full Text] [Related]
17. Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.
Koitabashi N; Aiba T; Hesketh GG; Rowell J; Zhang M; Takimoto E; Tomaselli GF; Kass DA
J Mol Cell Cardiol; 2010 Apr; 48(4):713-24. PubMed ID: 19961855
[TBL] [Abstract][Full Text] [Related]
18. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ
Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155
[TBL] [Abstract][Full Text] [Related]
19. Mild Chronic Kidney Disease Associated with Low Bone Formation and Decrease in Phosphate Transporters and Signaling Pathways Gene Expression.
Bogdanova E; Sadykov A; Ivanova G; Zubina I; Beresneva O; Semenova N; Galkina O; Parastaeva M; Sharoyko V; Dobronravov V
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108433
[TBL] [Abstract][Full Text] [Related]
20. The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.
Iemitsu M; Shimojo N; Maeda S; Irukayama-Tomobe Y; Sakai S; Ohkubo T; Tanaka Y; Miyauchi T
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H136-44. PubMed ID: 18456726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
